<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00190554</url>
  </required_header>
  <id_info>
    <org_study_id>JCOG9907</org_study_id>
    <secondary_id>C000000223</secondary_id>
    <nct_id>NCT00190554</nct_id>
  </id_info>
  <brief_title>A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma</brief_title>
  <official_title>A Randomized Controlled Trial of Chemotherapy With 5FU and Cisplatin Before and After Surgery for Stage II,III Squamous Cell Carcinoma of the Thoracic Esophagus:JCOG9907</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Japan Clinical Oncology Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Labour and Welfare, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Japan Clinical Oncology Group</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether chemotherapy before surgery makes better outcome than chemotherapy after
      surgery in patients with esophageal squamous cell carcinoma
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The previous study JCOG9204 showed that postoperative adjuvant chemotherapy with cisplatin
      and fluorouracil has a detectable preventive effect on relapse in patients with esophageal
      squamous cell carcinoma compared with surgery alone.(J Clin Oncol 2003;21:4592-4596)
      Therefore the standard treatment for stage II and III esophageal cancer is adjuvant
      chemotherapy after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>May 2000</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">May 2004</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity of chemotherapy</measure>
    <time_frame>year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative morbidity</measure>
    <time_frame>year</time_frame>
  </secondary_outcome>
  <enrollment>330</enrollment>
  <condition>Esophageal Neoplasms</condition>
  <condition>Carcinoma, Squamous Cell</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Surgery +(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>(Cisplatin 80 mg/㎡+5FU 800mg/㎡×5days)×2＋Surgery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. histologically proven squamous cell carcinoma of the thoracic esophagus

          2. pathologic stages IIa, IIb, III except T4

          3. an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2

          4. no previous history of chemotherapy nor radiotherapy

          5. an essentially normal clinical laboratory profile (white blood cell count or WBC,
             &gt;=4,000 /mm3; hemoglobin or Hb, &gt;=10g/dl; platelet count or Plt, &gt;=100,000 /mm3; total
             serum bilirubin&lt;=1.2 mg/dl; aspartate aminotransaminase or AST and alanine
             aminotransaminase or ALT no higher than twice normal; creatinine or CRTN, &lt;=1.2 mg/dl;
             creatinine clearance or CCr, &gt;=60 ml/minute; and arterial oxygen tension or PaO2, &gt;=65
             torr

          6. oral or written informed consent obtained before randomization

        Exclusion Criteria:

          1. severe heart diseases

          2. uncontrollable hyper tension or diabetes mellitus

          3. severe pulmonary dysfunction

          4. HBs positive

          5. active bacterial infection

          6. synchronous or metachronous (within 5 years) malignancy

          7. pregnant female

          8. psychiatric medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nobutoshi Ando, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Tokyo Dental College Ichikawa General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aichi Cancer Center Hospital</name>
      <address>
        <city>Nagoya,Chikusa-ku,Kanokoden,1-1</city>
        <state>Aichi</state>
        <zip>464-8681</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiba University, Graduate School of Medicine</name>
      <address>
        <city>Chiba,Chuo-ku,Inohana,1-8-1</city>
        <state>Chiba</state>
        <zip>260-8670</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Dental College Ichikawa General Hospital</name>
      <address>
        <city>Ichikawashi,Sugano,5-11-13</city>
        <state>Chiba</state>
        <zip>2728513</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital East</name>
      <address>
        <city>Kashiwa,Kashiwanoha,6-5-1</city>
        <state>Chiba</state>
        <zip>277-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Shikoku Cancer Center</name>
      <address>
        <city>Matsuyama,Horinouchi,13</city>
        <state>Ehime</state>
        <zip>790-0007</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kurume University School of Medicine</name>
      <address>
        <city>Kurume,Asahi-machi,67</city>
        <state>Fukuoka</state>
        <zip>830-0011</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hiroshima City Asa Hospital</name>
      <address>
        <city>Hiroshima,Asakitaku,KabeminamiHiroshima,2-1-1</city>
        <state>Hiroshima</state>
        <zip>731-0293</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iwate Medical University</name>
      <address>
        <city>Morioka,Uchimaru,19-1</city>
        <state>Iwate</state>
        <zip>020-8505</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokai University School of Medicine</name>
      <address>
        <city>Isehara,Shimokasuya,143</city>
        <state>Kanagawa</state>
        <zip>259-1193</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kanagawa Cancer Center</name>
      <address>
        <city>Yokohama,Asahi-ku,Nakao,1-1-2</city>
        <state>Kanagawa</state>
        <zip>241-0815</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>Kyoto,Sakyo-ku,Syogoinkawara,54</city>
        <state>Kyoto</state>
        <zip>606-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niigata University Medical and Dental Hospital</name>
      <address>
        <city>Niigata,Asahimachi-dori,1-754</city>
        <state>Niigata</state>
        <zip>951-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Niigata Cancer Center Hospital</name>
      <address>
        <city>Niigata,Kawagishi-cho,2-15-3</city>
        <state>Niigata</state>
        <zip>951-8566</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka National Hospital</name>
      <address>
        <city>Osaka,Chuo-ku,Hoenzaka,2-1-14</city>
        <state>Osaka</state>
        <zip>540-0006</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osaka Medical Center for Cancer and Cardiovascular Diseases</name>
      <address>
        <city>Osaka,Higashinari-ku,Nakamichi,1-3-3</city>
        <state>Osaka</state>
        <zip>537-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sizuoka Cancer Center</name>
      <address>
        <city>Sunto-gun,Nagaizumi-cho,Shimonagakubo,1007</city>
        <state>Shizuoka</state>
        <zip>411-8777</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tochigi Cancer Center</name>
      <address>
        <city>Utsunomiya,Yohnan,4-9-13</city>
        <state>Tochigi</state>
        <zip>320-0834</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Juntendo University School of Medicine</name>
      <address>
        <city>Bunkyo-ku,Hongo,3-1-3</city>
        <state>Tokyo</state>
        <zip>113-0033</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Medical and Dental University Hospital</name>
      <address>
        <city>Bunkyo-ku,Yushima,1-5-45</city>
        <state>Tokyo</state>
        <zip>113-8519</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Chuo-ku,Tsukiji,5-1-1</city>
        <state>Tokyo</state>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Tokyo Medical Center</name>
      <address>
        <city>Meguro-ku,Higashigaoka,2-5-1</city>
        <state>Tokyo</state>
        <zip>152-8902</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toranomon Hospital</name>
      <address>
        <city>Minato-ku,Toranomon,2-2-2</city>
        <state>Tokyo</state>
        <zip>105-8470</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tokyo Women's Medical University</name>
      <address>
        <city>Shinjuku-ku,Kawada-cho,8-1</city>
        <state>Tokyo</state>
        <zip>162-8666</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Keio University Hospital</name>
      <address>
        <city>Shinjuku-ku,Shinanomachi,35</city>
        <state>Tokyo</state>
        <zip>160-8582</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <link>
    <url>http://www.jcog.jp/</url>
  </link>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>September 20, 2016</last_update_submitted>
  <last_update_submitted_qc>September 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2016</last_update_posted>
  <keyword>esophageal cancer</keyword>
  <keyword>squamous cell carcinoma</keyword>
  <keyword>esophagectomy</keyword>
  <keyword>neoadjuvant chemotherapy</keyword>
  <keyword>esophageal squamous cell carcinoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cisplatin</mesh_term>
    <mesh_term>Fluorouracil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

